Literature DB >> 15073152

Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.

Yakov Pesah1, Tuan Pham, Heather Burgess, Brooke Middlebrooks, Patrik Verstreken, Yi Zhou, Mark Harding, Hugo Bellen, Graeme Mardon.   

Abstract

Mutations in the gene parkin in humans (PARK2) are responsible for a large number of familial cases of autosomal-recessive Parkinson disease. We have isolated a Drosophila homolog of human PARK2 and characterized its expression and null phenotype. parkin null flies have 30% lower mass than wild-type controls which is in part accounted for by a reduced cell size and number. In addition, these flies are infertile, show significantly reduced longevity, and are unable to jump or fly. Rearing mutants on paraquat, which generates toxic free radicals in vivo, causes a further reduction in longevity. Furthermore, loss of parkin results in progressive degeneration of most indirect flight muscle (IFM) groups soon after eclosion, accompanied by apoptosis. However, parkin mutants have normal neuromuscular junction recordings during the third larval instar stage, suggesting that larval musculature is intact and that parkin is required only in pupal and adult muscle. parkin flies do not show an age-dependent dopaminergic neuron loss in the brain, even after aging adults for 3 weeks. Nevertheless, degeneration of IFMs demonstrates the importance of parkin in maintaining specific cell groups, perhaps those with a high-energy demand and the concomitant production of high levels of free radicals. parkin mutants will be a valuable model for future analysis of the mechanisms of cell and tissue degeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073152     DOI: 10.1242/dev.01095

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  170 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

3.  Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.

Authors:  Cen Zhang; Meihua Lin; Rui Wu; Xiaowen Wang; Bo Yang; Arnold J Levine; Wenwei Hu; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

4.  The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax.

Authors:  Bethann N Johnson; Alison K Berger; Giuseppe P Cortese; Matthew J Lavoie
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-29       Impact factor: 11.205

5.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

6.  Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.

Authors:  Yufeng Yang; Stephan Gehrke; Md Emdadul Haque; Yuzuru Imai; Jon Kosek; Lichuan Yang; M Flint Beal; Isao Nishimura; Kazumasa Wakamatsu; Shosuke Ito; Ryosuke Takahashi; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

7.  Impaired neurotransmitter release in Alzheimer's and Parkinson's diseases.

Authors:  Jie Shen
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

8.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 9.  Programmed cell death and new discoveries in the genetics of parkinsonism.

Authors:  Robert E Burke
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.